Interface Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 1.00 M
- Company Age 25 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 7.95 M
- Satisfied Charges ₹ 1.55 M
- Revenue Growth 57.91%
- Profit Growth 98.90%
- Ebitda 79.08%
- Net Worth 53.51%
- Total Assets 43.08%
About Interface Pharmaceuticals
Interface Pharmaceuticals Pvt Ltd (IPPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 14 June 1999 and has a history of 25 years and ten months. Its registered office is in Delhi, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹7.95 M. The company has closed loans amounting to ₹1.55 M, as per Ministry of Corporate Affairs (MCA) records.
Sudhir Malhotra, Promila Malhotra, Manan Malhotra, and One other member serve as directors at the Company.
Company Details
- Location
Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24232DL1999PTC100229
- Company No.
100229
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
14 Jun 1999
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Pharma
Interface Pharmaceuticals Pvt Ltd
Explore comprehensive data for Interface Pharmaceuticals Pvt Ltd, including financials, compliance details, shareholding patterns, and litigation history.
Who are the key members and board of directors at Interface Pharmaceuticals?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Promila Malhotra  | Director | 14-Jun-1999 | Current |
| Sudhir Malhotra | Director | 14-Jun-1999 | Current |
| Manan Malhotra | Director | 25-Jul-2022 | Current |
| Shilpa Malhotra | Director | 20-Oct-2019 | Current |
Financial Performance of Interface Pharmaceuticals.
Interface Pharmaceuticals Pvt Ltd, for the financial year ended 2022, experienced significant growth in revenue, with a 57.91% increase. The company also saw a substantial improvement in profitability, with a 98.9% increase in profit. The company's net worth Soared by an impressive increase of 53.51%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Interface Pharmaceuticals?
In 2022, Interface Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
Open Charges
₹7.95 M
Satisfied Charges
₹1.55 M
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 0.80 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 18 Sep 2023 | Hdfc Bank Limited | ₹7.95 M | Open |
| 22 Nov 2008 | The Nainital Bank Limited | ₹0.90 M | Satisfied |
| 20 Sep 2004 | The Nainital Bank | ₹0.65 M | Satisfied |
How Many Employees Work at Interface Pharmaceuticals?
Unlock and access historical data on people associated with Interface Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Interface Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Interface Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Interface Pharmaceuticals
Recent activity within the organization
- Annual General Meeting
Interface Pharmaceuticals Pvt Ltd last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
- Balance Sheet
Interface Pharmaceuticals Pvt Ltd has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi.
- Charges
A charge with Hdfc Bank Limited amounted to Rs. 7.95 M with Charge ID 100820948 was registered on 18 Sep 2023.
- Charges
A charge registered on 22 Nov 2008 via Charge ID 10132572 with The Nainital Bank Limited was fully satisfied on 15 Sep 2022.
- Director Appointment
Manan Malhotra was appointed as a Director was appointed as a Director on 25 Jul 2022 & has been associated with this company since 2 years 9 months .
- Director Appointment
Shilpa Malhotra was appointed as a Director was appointed as a Director on 20 Oct 2019 & has been associated with this company since 5 years 6 months .
Frequently asked questions
What is the Incorporation or founding date of Interface Pharmaceuticals Pvt Ltd?
Interface Pharmaceuticals Pvt Ltd was incorporated on 14 Jun 1999.
What is authorized share capital and paid-up capital of Interface Pharmaceuticals Pvt Ltd?
The authorized share capital of Interface Pharmaceuticals Pvt Ltd is ₹ 1.00 M and paid-up capital is ₹ 1.00 M.
Who are the current board members & directors of Interface Pharmaceuticals Pvt Ltd?
Currently 4 directors are associated with Interface Pharmaceuticals Pvt Ltd.
- Sudhir Kumar Malhotra
- Promila Malhotra
- Manan Malhotra
- Shilpa Malhotra
What is the registered address of Interface Pharmaceuticals Pvt Ltd?
As per Ministry of Corporate Affairs (Mca), the registered address of Interface Pharmaceuticals Pvt Ltd is Ea-180, Maya Enclave India, New Delhi, 110064.
What is the corporate identification number (CIN) and company number of Interface Pharmaceuticals Pvt Ltd?
The corporate identification number (CIN) of Interface Pharmaceuticals Pvt Ltd is U24232DL1999PTC100229 and the company number is 100229 as per Ministry of Corporate Affairs (MCA).
What is the official website of Interface Pharmaceuticals Pvt Ltd?
The Official website of Interface Pharmaceuticals Pvt Ltd is https://www.interfacepharma.com
What has been the recent revenue trend for Interface Pharmaceuticals Pvt Ltd?
According to the financial reports for the fiscal year 2022, the revenue trend for Interface Pharmaceuticals Pvt Ltd has risen by 57.91%.
What change has been observed in the net worth of Interface Pharmaceuticals Pvt Ltd, and by what percentage?
The financial reports for the fiscal year 2022 indicates that The net worth of Interface Pharmaceuticals Pvt Ltd has experienced an upsurge of 53.51%.
What are the total open charges for Interface Pharmaceuticals Pvt Ltd?
As per the financial statements for fiscal Year 2022, The total open charges for Interface Pharmaceuticals Pvt Ltd amount to ₹ 7.95 M.
When was the last Balance Sheet of Interface Pharmaceuticals Pvt Ltd filed with the ROC?
The most recent Balance Sheet for Interface Pharmaceuticals Pvt Ltd was filed with the ROC on 31 Mar 2024.
Unlock Business Insights – Explore Instantly!
Search company & director profiles for free and gain access to critical business data.
- 3.1M+ Companies
- 15M+ Legal Cases
- 525K+ Credit Ratings
- 5.8M+ Directors & KMP
- 750K+ Regulatory Alerts
- 1.1M+ Companies' Financial Records